We are delighted to be joined online by Professor David Haylock - CEO of VivaZome therapeutics, and Dr Zahra Tajbakhsh from the School of Optometry and Vision Science, UNSW.

Professor Haylock's talk will provide industry insights into the development of exosome therapies for retinal degenerations, while Dr Tajbakhsh will present on the role of the ocular immune system in allergic conjunctivitis.